The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma
Official Title: PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma
Study ID: NCT01502228
Brief Summary: Given the growing importance of anti-angiogenic therapies in the treatment of metastatic renal carcinoma, it is expected that this trial will establish the preliminary data needed to apply for funding of a larger clinical investigation of the potential role of PET perfusion imaging in management of renal carcinoma, and potentially other cancers.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Indiana University Simon Cancer Center, Indianapolis, Indiana, United States
Name: James Fletcher, M.D.
Affiliation: Indiana University, Radiology
Role: PRINCIPAL_INVESTIGATOR
Name: Theodore Logan, M.D.
Affiliation: Indiana University, Dept. Medicine (Hem/Onc)
Role: PRINCIPAL_INVESTIGATOR